Add to Favourites
To login click here
CLEW Medical has received FDA clearance for their second-generation AI/machine-learning models that predict patient deterioration. This milestone highlights the company’s commitment to using AI to enhance care for critically ill patients and their adherence to rigorous regulatory processes. The CLEW platform offers health systems early identification of patient risk and has been found to be significantly more accurate than other telemedicine systems.
